Search

Your search keyword '"Benarab S"' showing total 12 results
Start Over Author "Benarab S"
12 results on '"Benarab S"'

8. Des abcès froids chez une enfant

Author

Benarab, S., primary, Faiz, S., additional, Wizla, N., additional, Racoussot, S., additional, Carette, S., additional, Catteau, B., additional, and Desmedt, E., additional

Published
2020
Full Text
View/download PDF

10. Prelingual Deafness: High Prevalence of a 30delG Mutation in the Connexin 26 Gene

Author

Denoyelle, F., primary, Weil, D., additional, Maw, M. A., additional, Wilcox, S. A., additional, Lench, N. J., additional, Allen-Powell, D. R., additional, Osborn, A. H., additional, Dahl, H.-H. M., additional, Middleton, A., additional, Houseman, M. J., additional, Dode, C., additional, Marlin, S., additional, Boulila-ElGaied, A., additional, Grati, M., additional, Ayadi, H., additional, BenArab, S., additional, Bitoun, P., additional, Lina-Granade, G., additional, Godet, J., additional, Mustapha, M., additional, Loiselet, J., additional, El-Zir, E., additional, Aubois, A., additional, Joannard, A., additional, Levilliers, J., additional, Garabedian, E.-N., additional, Mueller, R. F., additional, McKinlay Gardner, R. J., additional, and Petit, C., additional

Published
1997
Full Text
View/download PDF

11. Asymptomatic Acute Pancreatitis and Fulminant Type 1 Diabetes Mellitus: A Rare and Life-Threatening Complication in Drug Reaction With Eosinophilia and Systemic Symptoms.

Author

Benarab S, Dezoteux F, Stien S, Dambricourt V, and Duvert-Lehembre S

Subjects
Humans, Male, Acute Disease, Female, Adult, Eosinophilia chemically induced, Diabetes Mellitus, Type 1 complications, Pancreatitis chemically induced, Drug Hypersensitivity Syndrome etiology, Drug Hypersensitivity Syndrome diagnosis
Published
2024
Full Text
View/download PDF

12. Use of a subcutaneous implantable pleural port in the management of recurrent malignant pleurisy: five-year experience based on 168 subcutaneous implantable pleural ports.

Author

Kriegel I, Daniel C, Falcou MC, Marcou A, de Bosschère L, Benarab S, Livartowski A, and Estève M

Subjects
Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Pleurisy diagnostic imaging, Pleurisy drug therapy, Prospective Studies, Radiography, Young Adult, Catheters, Indwelling, Drainage methods, Pleural Effusion, Malignant physiopathology, Pleurisy physiopathology
Abstract

Introduction: The authors report their experience in the use of subcutaneous implantable pleural port (SIPP) catheters for the treatment of symptomatic recurrent malignant pleurisy., Materials and Methods: Single-center, prospective follow-up of 137 patients (168 SIPPs)., Results: No SIPP placement failures were observed. All but 3 of the 125 evaluable patients obtained complete or partial relief of their dyspnea. Seventy-six patients (60.3%) were receiving chemotherapy. Spontaneous pleurodesis was observed within 2 months in 46 patients (36.8%). Twenty-six patients (20.8%) died during the month following SIPP placement. Forty-one patients (32%) survived for more than 6 months. The overall median survival time was 344 days. Three infectious complications (1 empyema, 2 cellulitis) and 3 mechanical complications were observed. The role of pleurodesis as prognostic factor was assessed. Seventy-one patients survived for more than 2 months, 36 with pleurodesis, 35 without pleurodesis, requiring repeated pleural aspiration. The difference observed between the two groups by the 120th day was no longer significant when chemotherapy was taken into account., Conclusion: SIPP is a safe and effective option for the outpatient management of recurrent malignant effusions and could be considered as first-line treatment in all patients with bilateral, compressive pleural effusion or poor lung reexpansion.

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results